Advertisements

We're a little crazy, about science!

The Path of Antibiotic Resistance

resistance

MRSA, not that long ago we had no idea what MRSA was… mostly because it hadn’t come into prevalence. With an increase in the use and abuse of antibiotics there has been an ever growing pressure for the pathogens we treat to mutate in order to survive, this pressure is called selective pressure and helped cause drug-resistance in pathogens. In response to the rise of these drug-resistant pathogens, doctors are routinely cautioned against over prescribing antimicrobials. But when a patient has a confirmed bacterial infection, the advice is to treat aggressively to quash the infection before the bacteria can develop resistance.

A new study questions the accepted wisdom that aggressive treatment with high drug dosages and long durations is always the best way to stem the emergence and spread of resistant pathogens. The review of nearly 70 studies of antimicrobial resistance reveals the lack of evidence behind the practice of aggressive treatment in many cases.

“We found that while there are many studies that test for resistance emergence between different drug regimes, surprisingly few have looked at the topic of how varying drug dosage might affect the emergence and spread of resistance,” said Ruthie Birger, a Princeton graduate student.

“We are a long way from having the evidence for the best treatment decisions with respect to resistance for a range of diseases,” Birger said.

Microbes such as bacteria and parasites can evade today’s powerful drugs by undergoing genetic mutations that enable them to avoid being killed by the drug. For example, bacteria can develop enzymes that degrade certain antibiotics. The logic behind aggressive treatment goes something like this: kill off as many microbes as you can so that few will be around to evolve into resistant forms.

But some scientists have observed a different outcome in mice infected with both an already-resistant strain of malaria and a non-resistant strain. The high-dose drug treatment killed off the non-resistant malarial parasites, leaving the resistant strains to multiply and make the mice even sicker.

The idea that aggressive treatment may backfire against malarial parasites led the authors of the current study to comb the scientific literature to examine whether the same may be true for other types of microbes such as bacteria. The few studies that they found — mostly in laboratory cell cultures rather than animal models or patients — suggest that the picture is complicated, and depends on whether the resistance is new or existing, how many mutations are necessary for the pathogen to become resistant, and how long the drugs have been in use.

“It’s remarkable how little we know about this topic,” said Jessica Metcalf, an assistant professor of ecology and evolutionary biology. “The malaria study conducted by Silvie Huijben and colleagues at Pennsylvania State University is an inspiring step towards developing an evidence base for these important issues.”

In the current analysis, the study authors found that drug resistance is governed by two factors: the abundance of the pathogen and the strength of the selection pressure that drives the pathogen to evolve. Aggressive treatment deals with the first factor by killing off as much pathogen as possible, while moderate treatment may, for some pathogens, reduce the ability for the resistant pathogen to thrive (for example, by maintaining the competitive advantage of a co-infecting drug-sensitive strain of the pathogen) but still reduce total pathogen levels sufficiently that the patient can recover.

Finding the ideal dose and duration of treatment, one that cures the patient without aiding the spread of resistance, will likely be done on a disease by disease basis, the authors found.

One possibility is that moderate treatment might be best used against already-resistant microbes to prevent their spread. Moderate treatment may also be best for drugs that have been on the market for several years with plenty of time for resistant strains to develop.

Aggressive treatment might be best for pathogens that develop resistance slowly, over the course of several mutations. High doses early in the process could be effective at heading off the development of resistance.

The important thing to remember is that you don’t use antibiotics to treat viruses. Antibiotics are used to treat bacterial infections, gone are the days where doctors would give antibiotics to people with the flu to quell angry patients who felt they weren’t getting the healthcare they think they need. This might make a few people angry, but it is for the greater good.

Please, listen to Batman...

Please, listen to Batman…

Sources
Kouyos RD, Metcalf CJ, Birger R, Klein EY, Abel Zur Wiesch P, Ankomah P, Arinaminpathy N, Bogich TL, Bonhoeffer S, Brower C, Chi-Johnston G, Cohen T, Day T, Greenhouse B, Huijben S, Metlay J, Mideo N, Pollitt LC, Read AF, Smith DL, Standley C, Wale N, & Grenfell B (2014). The path of least resistance: aggressive or moderate treatment? Proceedings. Biological sciences / The Royal Society, 281 (1794) PMID: 25253451

Advertisements

But enough about us, what about you?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s